Emerging role of nuclear factor erythroid 2-related factor 2 in the mechanism of action and resistance to anticancer therapies

Poornima Paramasivan, Ibrahim H. Kankia, Simon P. Langdon, Yusuf Y. Deeni

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalCancer Drug Resistance
DOIs
Publication statusPublished - 3 Sep 2019

Cite this